Commercially Available Injectables in Diabetes – Insulin, Incretins, and More
The management of type 2 diabetes (T2D) has evolved significantly with the emergence of diverse medication classes, including metformin, sulfonylureas, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, sodium/glucose cotransporter 2 inhibitors, thiazolidinediones,...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2023-04-01
|
| Seri Bilgileri: | International Journal of Diabetes and Technology |
| Konular: | |
| Online Erişim: | https://journals.lww.com/10.4103/ijdt.ijdt_29_23 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|